V024-0262 Screening compound: 2-[2-({4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl}methyl)morpholine-4-carbonyl]quinoxaline

V024-0262 Screening compound: 2-[2-({4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl}methyl)morpholine-4-carbonyl]quinoxaline
V024-0262 Screening compound: 2-[2-({4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl}methyl)morpholine-4-carbonyl]quinoxaline alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-0262
2-[2-({4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl}methyl)morpholine-4-carbonyl]quinoxaline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-0262

Molecular Formula

C26H26F3N5O3 (C26 H26 F3 N5 O3)

Compound Name

2-[2-({4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl}methyl)morpholine-4-carbonyl]quinoxaline

IUPAC name

2-[2-({4-[4-(trifluoromethyl)benzoyl]piperazin-1-yl}methyl)morpholine-4-carbonyl]quinoxaline

SMILES

O=C(c1ccc(C(F)(F)F)cc1)N1CCN(CC(C2)OCCN2C(c2nc3ccccc3nc2)=O)CC1

InChI

InChI=1S/C26H26F3N5O3/c27-26(28,29)19-7-5-18(6-8-19)24(35)33-11-9-32(10-12-33)16-20-17-34(13-14-37-20)25(36)23-15-30-21-3-1-2-4-22(21)31-23/h1-8,15,20H,9-14,16-17H2/t20-/m0/s1

InChI Key

ORKCZFKJFCBTAI-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD19918713

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

513.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.690

Distribution Coefficient, logD

2.686

Water Solubility, LogSw

-2.73

Polar Surface Area

62.560

Acid Dissociation Constant (pKa)

26.69

Base Dissociation Constant (pKb)

5.43

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.50

V024-0262 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with V024-0262 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-0262?
Check Price and Availability of V024-0262, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-0262 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-0262
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-0262
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-0262 available by request